RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biomarkers biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 PMA postmarketing protocol safety statistical analysis toxicology transparency vaccines venture capital webinarCategories
- Clinical Trials (55)
- Conferences and Meetings (35)
- eCTD (26)
- FDA (78)
- Guest Posts (5)
- Health Canada (6)
- Industry News (62)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (39)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Monthly Archives: February 2010
GxP Lifeline features article by Cato’s Rachel Cooper
The February 2010 issue of the GxP Lifeline – Pharmaceutical newsletter made it’s debut today, and Cato Research Project Manager Rachel Cooper is highlighted as one of the featured authors. Rachel’s article, titled “From the Project Manager’s Toolbox: Strategies for … Continue reading
Cato at the DIA Electronic Data Management Conference
The Drug Information Association (DIA) will be holding its 23rd Annual Conference for Electronic Document Management on 16-19 February 2010 in National Harbor, MD (Baltimore-Washington Metro Area). Cato Research Regulatory Scientist Sybille Sauter will be one of three speakers during … Continue reading
January 2010 FDA Guidances
Each month, Cato Research Regulatory Scientist Cathy Anderson compiles a list of the notable guidance documents released by the FDA. Here’s a summary of the guidances released in January 2010 (links go directly to PDF documents). Assessment of Abuse Potential … Continue reading
